UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K/A

 

(Mark One)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2019

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM                      TO                     

Commission File Number: 001-38791

 

GORES METROPOULOS, INC.

(Exact name of registrant as specified in its Charter)

 

 

Delaware

 

83-1804317

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

 

 

9800 Wilshire Blvd.

 

 

Beverly Hills, CA

(Address of principal executive offices)

 

90212

(Zip Code)

Registrant’s telephone number, including area code: (310) 209-3010

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Name of each exchange on which registered

 

 

 

Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-third of one Warrant

 

Nasdaq Capital Market

Class A common stock, $0.0001 par value per share

 

Nasdaq Capital Market

Warrants to purchase Class A common stock

 

Nasdaq Capital Market

 

Securities registered pursuant to Section 12(g) of the Act:

None

 

Title of each class

 

Trading Symbols

 

Name of each exchange on which registered

Class A Common Stock

 

GMHI

 

Nasdaq Capital Market

Warrants

 

GMHIW

 

Nasdaq Capital Market

Units

 

GMHIU

 

Nasdaq Capital Market

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES  NO 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. YES  NO 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES  NO   

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YES  NO 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. (See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act).

 

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

 

Smaller reporting company

Emerging growth company

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES  NO 

As of June 28, 2019, the aggregate market value of shares held by non-affiliates of the registrant (based upon the closing sale prices of such shares on the Nasdaq Global Select Market on June 28, 2019) was approximately $402.8 million. For purposes of calculating the aggregate market value of shares held by non-affiliates, we have assumed that all outstanding shares are held by non-affiliates, except for shares held by each of our executive officers, directors and 5% or greater stockholders. In the case of 5% or greater stockholders, we have not deemed such


 

stockholders to be affiliates unless there are facts and circumstances which would indicate that such stockholders exercise any control over our company, or unless they hold 10% or more of our outstanding common stock. These assumptions should not be deemed to constitute an admission that all executive officers, directors and 5% or greater stockholders are, in fact, affiliates of our company, or that there are not other persons who may be deemed to be affiliates of our company. Further information concerning shareholdings of our officers, directors and principal stockholders is included or incorporated by reference in Part III, Item 12 of this Annual Report on Form 10-K.

As of March 13, 2020, there were 40,000,000 shares of the Company’s Class A common stock, par value $0.0001 per share, and 10,000,000 shares of the Company’s Class F common stock, par value $0.0001 per share, issued and outstanding.

 

 


 

Explanatory Note

 

Gores Metropoulos, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K (this “Amendment”) to amend our annual report on Form 10-K for the year ended December 31, 2019, as filed with the Securities and Exchange Commission on March 13, 2020, and is being filed solely to correct the Company’s accelerated filer status included in the submission header and XBRL DEI. The correct filer status for “Accelerated” was marked on the Form 10-K cover page, however the incorrect filer status of “Non-Accelerated” was inadvertently included in the submission header and XBRL DEI file.

 

This Amendment speaks as of the original filing date and does not reflect any events that may have occurred subsequent to the original filing date. In addition, pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended, as a result of this Amendment, the certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed, as exhibits to the original filing have been re-executed and re-filed as of the date of this Amendment and are included as exhibits hereto.

 

Except as stated herein, this Amendment does not reflect events occurring after the filing of the Form 10-K on March 13, 2020 and no attempt has been made in this Amendment to modify or update other disclosures as presented in the  Form 10-K. This Form 10-K/A has not been updated for events occurring after the filing of the Form 10-K and no attempt has been made in this Form 10-K/A to modify or update other disclosures as presented in the original filing of the Form 10-K. The following sections have been amended as a result of the restatement:

 

 

-

Part IV, Item 15. Exhibits, Financial Statement Schedules

 

In accordance with applicable SEC rules, this Form 10-K/A includes certifications from our Chief Executive Officer and Principal Financial Officer dated as of the date of this filing.


 

PART IV

Item 15.

Exhibits, and Financial Statement Schedules

 

(a)

The following documents are filed as part of this Annual Report on Form 10-K:

Financial Statements:  The financial statements listed in “Index to the Financial Statements” at “Item 8. Financial Statements and Supplementary Data” are filed as part of this Annual Report on Form 10-K.

 

(b)

Exhibits:  The exhibits listed in the accompanying index to exhibits are filed or incorporated by reference as part of this Annual Report on Form 10-K.

 

Exhibit

Number

  

Description

 

 

 

    3.1

 

Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed with the SEC on February 6, 2019).

 

 

 

    3.2

 

By Laws (incorporated by reference to Exhibit 3.3 filed with the Form S-1 filed by the Registrant on December 11, 2018).

 

 

 

    4.1

 

Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 filed with the Form S-1 filed by the Registrant on December 11, 2018).

 

 

 

    4.2

 

Specimen Class A Common Stock Certificate (incorporated by reference to Exhibit 4.2 filed with the Form S-1 filed by the Registrant on December 11, 2018).

 

 

 

    4.3

 

Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 filed with the Form S-1 filed by the Registrant on December 11, 2018).

 

 

 

    4.4

 

Warrant Agreement, dated January 31, 2019, between the Company and Continental Stock Transfer & Trust Company, as warrant agent (incorporated by reference to Exhibit 4.1 of the Company’s Current Report on Form 8-K filed with the SEC on February 6, 2019).

 

 

 

   10.1

 

Promissory Note, dated October 18, 2018, issued to Gores Metropoulos Sponsor, LLC (incorporated by reference to Exhibit 10.1 to the Form S-1 filed by the Registrant on December 11, 2018).

 

 

 

   10.2

 

Investment Management Trust Agreement, dated January 31, 2019, between the Company and Continental Stock Transfer & Trust Company, as trustee (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on February 6, 2019).

 

 

 

   10.3

 

Registration Rights Agreement, dated January 31, 2019, among the Company, Gores Metropoulos Sponsor, LLC and certain other security holders named therein (incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on February 6, 2019).

 

 

 

   10.4

 

Sponsor Warrants Purchase Agreement effective as of January 30, 2019, between the Registrant and Gores Metropoulos Sponsor, LLC (incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on February 6, 2019).

 

 

 

   10.5

 

Administrative Services Agreement, dated January 31, 2019, between the Company and The Gores Group, LLC (incorporated by reference to Exhibit 10.4 of the Company’s Current Report on Form 8-K filed with the SEC on February 6, 2019).


 

Exhibit

Number

  

Description

 

 

 

   10.6

 

Letter Agreement, dated February 1, 2019, among the Company, its officers and directors and Gores Metropoulos Sponsor, LLC (incorporated by reference to Exhibit 10.5 of the Company’s Current Report on Form 8-K filed with the SEC on February 6, 2019).

 

 

 

   10.7

 

Form of Indemnity Agreement (incorporated by reference to Exhibit 10.7 filed with the Form S-1 filed by the Registrant on December 11, 2018).

 

 

 

   10.8

 

Securities Subscription Agreement, dated October 18, 2018, between the Registrant and Gores Metropoulos Sponsor, LLC (incorporated by reference to Exhibit 10.5 filed with the Form S-1 filed by the Registrant on December 11, 2018).

 

 

 

   31.1*

 

Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

   31.2*

 

Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

101.INS*

 

XBRL Instance Document

 

 

 

101.SCH*

 

XBRL Taxonomy Extension Schema

 

 

 

101.CAL*

 

XBRL Taxonomy Extension Calculation Linkbase

 

 

 

101.DEF*

 

XBRL Taxonomy Extension Definition Linkbase

 

 

 

101.LAB*

 

XBRL Taxonomy Extension Label Linkbase

 

 

 

101.PRE*

 

XBRL Taxonomy Extension Presentation Linkbase

 

*

Filed herewith.



 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

GORES METROPOULOS, INC.

 

 

Date: March 26, 2020By:  /s/ Alec Gores

 

Alec Gores

Chief Executive Officer

(Principal Executive Officer)

gmhi-ex311_27.htm

EXHIBIT 31.1

CERTIFICATION PURSUANT TO

RULES 13a‑14(a) AND 15d‑14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Alec Gores, certify that:

1.I have reviewed this Annual Report on Form 10‑K/A of Gores Metropoulos, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statement made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a‑15(e) and 15d‑15(e)) for the registrant and have

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and

5.The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls over financial reporting.

Date: March 26, 2020

 

 

 

/s/ Alec Gores

 

Alec Gores

 

Chief Executive Officer

 

(Principal Executive Officer)

 

gmhi-ex312_26.htm

EXHIBIT 31.2

CERTIFICATION PURSUANT TO

RULES 13a‑14(a) AND 15d‑14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Andrew McBride, certify that:

1.I have reviewed this Annual Report on Form 10‑K/A of Gores Metropoulos, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statement made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a‑15(e) and 15d‑15(e)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and

5.The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls over financial reporting.

Date: March 26, 2020

 

/s/ Andrew McBride

 

Andrew McBride

 

Chief Financial Officer

 

(Principal Financial and Accounting Officer)

 

v3.20.1
Related Party Transactions - Additional Information (Details)
4 Months Ended 12 Months Ended
Mar. 18, 2019
shares
Feb. 05, 2019
$ / shares
shares
Jan. 25, 2019
USD ($)
Oct. 18, 2018
USD ($)
$ / shares
shares
Dec. 31, 2018
Dec. 31, 2019
USD ($)
$ / shares
shares
Related Party Transaction [Line Items]            
Sale of common stock, value | $           $ 400,000,000
Number of warrants sold | shares           6,666,666
Warrants sold, price per warrant | $ / shares           $ 1.50
Proceeds from sale of Private Placement Warrants to Sponsor | $           $ 10,000,000
IPO            
Related Party Transaction [Line Items]            
Unit price (in dollars per Unit) | $ / shares   $ 10.00        
Class F Common Stock            
Related Party Transaction [Line Items]            
Number of shares forfeited | shares           781,250
Class A Common Stock            
Related Party Transaction [Line Items]            
Sale of common stock (in shares) | shares           40,000,000
Sale of common stock, value | $           $ 4,000
Unit price (in dollars per Unit) | $ / shares           $ 10.00
Class A Common Stock | IPO            
Related Party Transaction [Line Items]            
Sale of common stock (in shares) | shares   40,000,000       40,000,000
Founder Shares            
Related Party Transaction [Line Items]            
Outstanding shares of common stock held by the initial stockholders (as a percent) 20.00%          
Founder Shares | Class A Common Stock            
Related Party Transaction [Line Items]            
Conversion ratio         1  
Founder Shares | Sponsor            
Related Party Transaction [Line Items]            
Number of shares forfeited | shares 781,250          
Founder Shares | Sponsor | Class F Common Stock            
Related Party Transaction [Line Items]            
Sale of common stock (in shares) | shares       10,781,250    
Sale of common stock, value | $       $ 25,000    
Unit price (in dollars per Unit) | $ / shares       $ 0.002    
Founder Shares | Director            
Related Party Transaction [Line Items]            
Number of shares transferred | shares       75,000    
Private Placement Warrants | Class A Common Stock            
Related Party Transaction [Line Items]            
Number of shares warrant may be converted | shares           1
Warrants exercise price (in dollars per share) | $ / shares           $ 11.50
Private Placement Warrants | Sponsor            
Related Party Transaction [Line Items]            
Number of warrants sold | shares       6,666,666    
Warrants sold, price per warrant | $ / shares       $ 1.50    
Proceeds from sale of Private Placement Warrants to Sponsor | $       $ 10,000,000    
Sponsor Loan | IPO            
Related Party Transaction [Line Items]            
Expenses related to public offering | $       300,000    
Proceeds from Promissory Note to related party | $     $ 150,000 $ 150,000    
Unsecured promissory note | $           $ 150,000
Administrative Service Agreement | Affiliate of the Sponsor            
Related Party Transaction [Line Items]            
Monthly charge for administrative services | $           $ 20,000
v3.20.1
Organization and Business Operations - Additional Information (Details) - USD ($)
12 Months Ended
Feb. 05, 2019
Dec. 31, 2019
Organization Consolidation And Presentation Of Financial Statements [Line Items]    
Amount placed in trust account $ 400,000,000  
Proceeds from sale of Units in initial public offering 400,000,000 $ 400,000,000
Proceeds from sale of Private Placement Warrants to Sponsor   $ 10,000,000
Maximum maturity period   180 days
Regulatory withdrawal of interest from trust account, annual limit   $ 750,000
Regulatory withdrawal of interest from trust account, maximum period   24 months
Redemption percentage if business combination is not completed   100.00%
Number of days to seek shareholder approval for redemption of shares   2 days
Number of days to provide opportunity to shareholders to sell their shares   2 days
Dissolution expenses, maximum allowed   $ 100,000
Minimum    
Organization Consolidation And Presentation Of Financial Statements [Line Items]    
Percentage of fair market value   80.00%
Maximum    
Organization Consolidation And Presentation Of Financial Statements [Line Items]    
Number of months to complete business combination   24 months
Threshold net tangible assets   $ 5,000,001
Number of days to redeem the shares if Business combination is not completed   10 days
Private Placement    
Organization Consolidation And Presentation Of Financial Statements [Line Items]    
Proceeds from sale of Private Placement Warrants to Sponsor $ 10,000,000  
v3.20.1
Investments and Cash Held In Trust
12 Months Ended
Dec. 31, 2019
Investments And Cash Held In Trust [Abstract]  
Investments and Cash Held In Trust

7.

Investments and cash held in Trust

As of December 31, 2019, investment securities in the Company’s Trust Account consist of $406,434,735 in United States Treasury Bills and $224 in cash.

v3.20.1
Public Offering
12 Months Ended
Dec. 31, 2019
Public Offering [Abstract]  
Public Offering

3.

Public Offering

Public Units

On February 5, 2019, the Company sold 40,000,000 units at a price of $10.00 per unit (the “Units”), including 2,500,000 Units as a result of the underwriter’s partial exercise of their over-allotment option, generating gross proceeds of $400,000,000. Each Unit consists of one share of the Company’s Class A common stock, $0.0001 par value, and one-third of one redeemable Class A common stock purchase warrant (the “Warrants”). Each Whole Warrant entitles the holder to purchase one share of Class A common stock for $11.50 per share. Each Warrant will become exercisable on the later of 30 days after the completion of the Business Combination or 12 months from the closing of the Public Offering and will expire five years after the completion of the Business Combination or earlier upon redemption or liquidation. However, if the Company does not complete the Business Combination on or prior to the 24-month period allotted to complete the Business Combination, the Warrants will expire at the end of such period. The Warrants were issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and the Company. The Company did not register the shares of Common Stock issuable upon exercise of the Warrants under the Securities Act of 1933, as amended (the “Securities Act”) or any state securities law. Under the terms of the warrant agreement, the Company has agreed to use its best efforts to file a registration statement under the Securities Act following the completion of the Business Combination covering the shares of Common Stock issuable upon exercise of the Warrants. The Company paid an upfront underwriting discount of 2.00% ($8,000,000) of the per Unit offering price to the underwriters at the closing of the Public Offering, with an additional fee (the “Deferred Discount”) of 3.50% ($14,000,000) of the per Unit offering price payable upon the Company’s completion of a Business Combination. The Deferred Discount will become payable to the underwriters from the amounts held in the Trust Account solely in the event the Company completes its Business Combination.

v3.20.1
Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (“SEC”), and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position as of December 31, 2019 and 2018 and the results of operations and cash flows for the periods presented.

Net Income/(Loss) Per Common Share

Net Income/(Loss) Per Common Share

The Company has two classes of shares, which are referred to as Class A common stock (the “Common Stock”) and Class F common stock (the “Founder Shares”). Net income/(loss) per common share is computed utilizing the two-class method. The two-class method is an earnings allocation formula that determines earnings per share separately for each class of common stock based on an allocation of undistributed earnings per the rights of each class. As of December 31, 2019, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company under the treasury stock method. As a result, diluted net income/(loss) per common share is the same as basic net income/(loss) per common share for the period. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income/(loss) per share for each class of common stock:

 

 

Year Ended December 31, 2019

 

 

For the Period from August 28, 2018 (inception) to December 31, 2018

 

 

 

Class A

 

 

Class F

 

 

Class A

 

 

Class F

 

Basic and diluted net income/(loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allocation of net income/(loss)

 

$

 

5,938,019

 

 

$

 

(492,843

)

 

$

 

 

 

$

 

(21,985

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average shares outstanding

 

 

 

36,164,000

 

 

 

 

10,162,656

 

 

 

 

 

 

 

 

10,781,250

 

Basic and diluted net income/(loss) per share

 

$

 

0.16

 

 

$

 

(0.05

)

 

$

 

 

 

$

 

(0.00

)

 

Concentration of Credit Risk

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution as well as the Trust Account, which at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts.

Financial Instruments

Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic  820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet.

Offering Costs

Offering Costs

The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A — “Expenses of Offering.” Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to our Public Offering reflected in Deferred offering costs on the accompanying December 31, 2018 balance sheet, and were charged to stockholders’ equity upon the completion of our Public Offering. Accordingly, on the IPO Closing Date, offering costs totaling approximately $22,865,105 (including $22,000,000 in underwriter’s fees), were charged to stockholders’ equity.

Redeemable Common Stock

Redeemable Common Stock

As discussed in Note 3, all of the 40,000,000 shares of Common Stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation. In accordance with ASC 480, redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Although the Company did not specify a maximum redemption threshold, its amended and restated certificate of incorporation provides that currently, the Company will not redeem its public shares in an amount that would cause its net tangible assets (stockholders’ equity) to be less than $5,000,001.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital.

Accordingly, as of December 31, 2019, 38,713,476 of the 40,000,000 public shares are classified outside of permanent equity at their redemption value.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Income Taxes

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

The Company accounts for uncertainty in income taxes by recognizing the tax benefit from an uncertain tax position only if it is more than likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits recognized in the financial statements from such a position based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution. The application of income tax law is inherently complex. Laws and regulations in this area are voluminous and are often ambiguous. As such, the Company is required to make many subjective assumptions and judgments regarding income tax exposures. Interpretations of and guidance surrounding income tax law and regulations change over time and may result in changes to the Company's subjective assumptions and judgments, which can materially affect amounts recognized in the balance sheets and statements of operations. The Company recognizes interest and penalties related to uncertain tax positions in other income (expense). No penalties or interest were recorded during the years ended December 31, 2019 or 2018.

The Company may be subject to potential examination by U.S. federal, states or foreign jurisdiction authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income amounts various tax jurisdictions and compliance with U.S. federal, states or foreign tax laws.

The Company is incorporated in the State of Delaware and is required to pay franchise taxes to the State of Delaware on an annual basis.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company continually monitors its positions with and the credit quality of the financial institutions with which it invests. Periodically, the Company may maintain balances in various operating accounts in excess of federally insured limits.

Investments and Cash Held in Trust Account

Investments and Cash Held in Trust Account

As of December 31, 2019, the Company had $406,434,959 in the Trust Account which may be utilized for Business Combinations. As of December 31, 2019, the Trust Account consisted of both cash and treasury bills.

The Company’s amended and restated certificate of incorporation provides that, other than the withdrawal of interest to pay taxes, if any, none of the funds held in trust will be released until the earlier of: (i) the completion of the Business Combination; (ii) the redemption of any public shares of common stock properly tendered in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of such public shares of common stock if the Company does not complete the Business Combination within 24 months from the IPO Closing Date; or (iii) the redemption of 100% of the public shares of common stock if the Company is unable to complete a Business Combination within 24 months from the IPO Closing Date, subject to the requirements of law and stock exchange rules.

Recently issued accounting pronouncements not yet adopted

Recently issued accounting pronouncements not yet adopted

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements based on current operations of the Company.  The impact of any recently issued accounting standards will be re-evaluated on a regular basis or if a Business Combination is completed where the impact could be material.

Going Concern Consideration

Going Concern Consideration

If the Company does not complete its Business Combination by February 5, 2021, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the common stock sold as part of the units in the Public Offering, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of franchise and income taxes payable and less up to $100,000 of such net interest which may be distributed to the Company to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s Board of Directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the initial public offering price per unit (the “Units”) in the Public Offering. In addition if the Company fails to complete its Business Combination by February 5, 2021, there will be no redemption rights or liquidating distributions with respect to the warrants, which will expire worthless.

In addition, as of December 31, 2019 and 2018, the Company had current liabilities of $1,355,865 and $486,849, respectively, and working capital of $145,774 and $3,015, respectively, largely due to amounts owed to professionals, consultants, advisors and others who are working on seeking a Business Combination as described in Note 1. Such work is continuing after December 31, 2019 and amounts are continuing to accrue.

v3.20.1
Fair Value Measurements - Schedule of Assets Measured at Fair Value on Recurring Basis (Details) - Fair Value, Measurements, Recurring
Dec. 31, 2019
USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Investments and cash held in Trust Account $ 406,434,959
Total 406,434,959
Quoted Prices in Active Markets (Level 1)  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Investments and cash held in Trust Account 406,434,959
Total $ 406,434,959
v3.20.1
STATEMENTS OF OPERATIONS - USD ($)
4 Months Ended 12 Months Ended
Dec. 31, 2018
Dec. 31, 2019
Professional fees and other expenses $ (20,554) $ (620,871)
State franchise taxes, other than income tax (1,431) (200,000)
Loss from operations (21,985) (820,871)
Other income - interest income   7,707,654
Net income/(loss) before income taxes (21,985) 6,886,783
Provision for income tax   (1,441,607)
Net income/(loss) attributable to common shares (21,985) 5,445,176
Class A Common Stock    
Net income/(loss) attributable to common shares   $ 5,938,019
Net income/(loss) per ordinary share:    
Net income (loss) per ordinary share - basic and diluted   $ 0.16
Class F Common Stock    
Net income/(loss) attributable to common shares $ (21,985) $ (492,843)
Net income/(loss) per ordinary share:    
Net income (loss) per ordinary share - basic and diluted $ 0.00 $ (0.05)
v3.20.1
Organization and Business Operations
12 Months Ended
Dec. 31, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Organization and Business Operations

1.

Organization and Business Operations

Organization and General

Gores Metropoulos, Inc. (the “Company”) was incorporated in Delaware on August 28, 2018. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar Business Combination with one or more businesses (the “Business Combination”). The Company has neither engaged in any operations nor generated any revenue to date. The Company’s management has broad discretion with respect to the Business Combination, but intends to focus our search for a target business in the consumer products and services industries. The Company’s Sponsor is Gores Metropoulos Sponsor, LLC, a Delaware limited liability company (the “Sponsor”). The Company has selected December 31 as its fiscal year-end.

At December 31, 2019, the Company had not commenced any operations. All activity for the period from August 28, 2018 (inception) through December 31, 2019 relates to the Company’s formation and initial public offering (“Public Offering”) described below. The Company completed the Public Offering on February 5, 2019. The Company will not generate any operating revenues until after the completion of its Business Combination, at the earliest. Subsequent to the Public Offering, the Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Public Offering and the sale of the Private Placement Warrants (as defined below) held in the Trust Account (as defined below).

Financing

Upon the closing of the Public Offering and the sale of the Private Placement Warrants, an aggregate of $400,000,000 was placed in a Trust Account with Continental Stock Transfer & Trust Company (the “Trust Account”) acting as Trustee.

The Company intends to finance a Business Combination with the net proceeds from its $400,000,000 Public Offering and its sale of $10,000,000 of Private Placement Warrants.

Trust Account

Funds held in the Trust Account can be invested only in U.S. government treasury bills with a maturity of one hundred and eighty (180) days or less or in money market funds meeting certain conditions under Rule 2a 7 under the Investment Company Act of 1940, as amended, that invest only in direct U.S. government obligations. As of December 31, 2019, the Trust Account consisted of cash and treasury bills.

The Company’s amended and restated certificate of incorporation provides that, other than the withdrawal of interest to fund regulatory compliance requirements and other costs related thereto (a “Regulatory Withdrawal”), subject to an annual limit of $750,000 for a maximum 24 months and/or additional amounts necessary to pay franchise and income taxes, if any, none of the funds held in trust will be released until the earliest of: (i) the completion of the Business Combination; or (ii) the redemption of any public shares of common stock properly tendered in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of such public shares of common stock if the Company does not complete the Business Combination within 24 months from the IPO Closing Date; or (iii) the redemption of 100% of the public shares of common stock if the Company is unable to complete a Business Combination within 24 months from the IPO Closing Date, subject to the requirements of law and stock exchange rules.

Business combination

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering, although substantially all of the net proceeds of the Public Offering are intended to be generally applied toward consummating a Business Combination. The Business Combination must be with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (less any deferred underwriting commissions and taxes payable on interest income earned) at the time of the Company signing a definitive agreement in connection with the Business Combination. Furthermore, there is no assurance that the Company will be able to successfully effect a Business Combination.

The Company, after signing a definitive agreement for a Business Combination, will either (i) seek stockholder approval of the Business Combination at a meeting called for such purpose in connection with which stockholders may seek to redeem their shares, regardless of whether they vote for or against the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the Business Combination, including interest income but less taxes payable, or (ii) provide stockholders with the opportunity to sell their shares to the Company by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the Business Combination, including interest income but less taxes payable. The decision as to whether the Company will seek stockholder approval of the Business Combination or will allow stockholders to sell their shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval, unless a vote is required by law or under NASDAQ rules. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the outstanding shares of Common Stock voted are voted in favor of the Business Combination. Currently, the Company will not redeem its public shares of Common Stock in an amount that would cause its net tangible assets to be less than $5,000,001. In such case, the Company would not proceed with the redemption of its public shares of Common Stock and the related Business Combination, and instead may search for an alternate Business Combination.

As a result of the foregoing redemption provisions, the public shares of Common Stock will be recorded at redemption amount and classified as temporary equity, in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic  480, “Distinguishing Liabilities from Equity” (“ASC 480”) in subsequent periods.

The Company will have 24 months from the IPO Closing Date to complete its Business Combination. If the Company does not complete a Business Combination within this period of time, it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the public shares of  Common Stock for a per share pro rata portion of the Trust Account, including interest income, but less taxes payable (less up to $100,000 of such net interest income to pay dissolution expenses) and (iii) as promptly as possible following such redemption, dissolve and liquidate the balance of the Company’s net assets to its remaining stockholders, as part of its plan of dissolution and liquidation. The Sponsor and the Company’s officers and directors have entered into a letter agreement with the Company, pursuant to which they waived their rights to participate in any redemption with respect to their Founder Shares (as defined below); however, if the Sponsor or any of the Company’s officers, directors or affiliates acquire public shares of Common Stock, they will be entitled to a pro rata share of the Trust Account in the event the Company does not complete a Business Combination within the required time period.

In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the initial public offering price per Unit in the Public Offering.

Emerging Growth Company

Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

v3.20.1
Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Reconciliation of Numerator and Denominator Used to Compute Basic and Diluted Net Income/(loss) Per Share The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income/(loss) per share for each class of common stock:

 

 

Year Ended December 31, 2019

 

 

For the Period from August 28, 2018 (inception) to December 31, 2018

 

 

 

Class A

 

 

Class F

 

 

Class A

 

 

Class F

 

Basic and diluted net income/(loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allocation of net income/(loss)

 

$

 

5,938,019

 

 

$

 

(492,843

)

 

$

 

 

 

$

 

(21,985

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average shares outstanding

 

 

 

36,164,000

 

 

 

 

10,162,656

 

 

 

 

 

 

 

 

10,781,250

 

Basic and diluted net income/(loss) per share

 

$

 

0.16

 

 

$

 

(0.05

)

 

$

 

 

 

$

 

(0.00

)

v3.20.1
Fair Value Measurements
12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurements

8.

Fair Value Measurements

The Company complies with FASB ASC 820, Fair Value Measurements, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. ASC 820 determines fair value to be the price that would be received to sell an asset or would be paid to transfer a liability (i.e., the exit price) in an orderly transaction between market participants at the measurement date.

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of December 31, 2019, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Fair values determined by Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves. Fair values determined by Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability:

 

 

 

 

 

 

 

 

 

 

 

 

Significant

 

 

Significant

 

 

 

 

 

 

 

 

 

 

 

 

 

Other

 

 

Other

 

 

 

 

 

 

 

 

Quoted Prices in

 

 

Observable

 

 

Unobservable

 

 

 

December 31,

 

 

Active Markets

 

 

Inputs

 

 

Inputs

 

Description

 

2019

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

Investments and cash held in Trust Account

 

 

 

406,434,959

 

 

 

 

406,434,959

 

 

 

 

 

 

 

 

 

Total

 

$

 

406,434,959

 

 

$

 

406,434,959

 

 

$

 

 

 

$

 

 

 

v3.20.1
Related Party Transactions
12 Months Ended
Dec. 31, 2019
Related Party Transactions [Abstract]  
Related Party Transactions

4.

Related Party Transactions

Founder Shares

On October 18, 2018, the Sponsor purchased 10,781,250 shares of Class F common stock (the “Founder Shares”) for an aggregate purchase price of $25,000, or approximately $0.002 per share. Subsequently, the Sponsor transferred an aggregate of 75,000 Founder Shares to the Company’s independent directors (together with the Sponsor, the “Initial Stockholders”). On March 18, 2019, the Sponsor forfeited 781,250 Founder Shares following the expiration of the unexercised portion of underwriter’s over-allotment option, so that the Founder Shares held by the Initial Stockholders would represent 20.0% of the outstanding shares of Common Stock following completion of the Public Offering. The Founder Shares are identical to the Common Stock included in the Units sold in the Public Offering except that the Founder Shares will automatically convert into shares of Class A common stock at the time of the Business Combination on a one-for-one basis, subject to adjustment as described in the Company’s amended and restated certificate of incorporation.

Private Placement Warrants

The Sponsor purchased from the Company an aggregate of 6,666,666 warrants at a price of $1.50 per warrant (a purchase price of $10,000,000) in a private placement that occurred simultaneously with the Public Offering (the “Private Placement Warrants”). Each Private Placement Warrant entitles the holder to purchase one share of Class A common stock at $11.50 per share. A portion of the purchase price of the Private Placement Warrants was added to the proceeds from the Public Offering to be held in the Trust Account pending completion of the Business Combination.

The Private Placement Warrants have terms and provisions that are identical to those of the Warrants sold as part of the Units in the Public Offering, except that the Private Placement Warrants may be physical (cash) or net share (cashless) settled and are not redeemable so long as they are held by the Sponsor or its permitted transferees.

If the Company does not complete a Business Combination, then the Private Placement Warrants proceeds will be part of the liquidation distribution to the public stockholders and the Private Placement Warrants will expire worthless.

Registration Rights

The holders of Founder Shares, Private Placement Warrants and warrants issued upon conversion of working capital loans, if any, have registration rights (in the case of the Founder Shares, only after conversion of such shares to common shares) pursuant to a registration rights agreement entered into by the Company, the Sponsor and the other security holders named therein on February 1, 2019. These holders will also have certain demand and “piggy back” registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Sponsor Loan

On October 18, 2018, our Sponsor loaned us an aggregate of $150,000 by the issuance of an unsecured promissory note for $300,000 to cover expenses related to the Public Offering. On December 31, 2019, the outstanding balance on the loan was $150,000. On January 25, 2019, our Sponsor loaned us an additional $150,000 to cover expenses related to the Public Offering. These Notes were non-interest bearing and payable on the earlier of September 30, 2019 or the completion of the Public Offering. The carrying amount of the Notes approximates fair value because of their short maturity. These Notes were repaid in full upon the completion of the Public Offering.

Administrative Service Agreement

The Company entered into an administrative services agreement on February 1, 2019, pursuant to which it agreed to pay to an affiliate of the Sponsor $20,000 a month for office space, utilities and secretarial support. Services commenced on the date the securities were first listed on the NASDAQ Capital Market and will terminate upon the earlier of the consummation by the Company of a Business Combination or the liquidation of the Company.

v3.20.1
Significant Accounting Policies
12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Significant Accounting Policies

2.

Significant Accounting Policies

Basis of Presentation

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (“SEC”), and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position as of December 31, 2019 and 2018 and the results of operations and cash flows for the periods presented.

Net Income/(Loss) Per Common Share

The Company has two classes of shares, which are referred to as Class A common stock (the “Common Stock”) and Class F common stock (the “Founder Shares”). Net income/(loss) per common share is computed utilizing the two-class method. The two-class method is an earnings allocation formula that determines earnings per share separately for each class of common stock based on an allocation of undistributed earnings per the rights of each class. As of December 31, 2019, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company under the treasury stock method. As a result, diluted net income/(loss) per common share is the same as basic net income/(loss) per common share for the period. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income/(loss) per share for each class of common stock:

 

 

Year Ended December 31, 2019

 

 

For the Period from August 28, 2018 (inception) to December 31, 2018

 

 

 

Class A

 

 

Class F

 

 

Class A

 

 

Class F

 

Basic and diluted net income/(loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allocation of net income/(loss)

 

$

 

5,938,019

 

 

$

 

(492,843

)

 

$

 

 

 

$

 

(21,985

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average shares outstanding

 

 

 

36,164,000

 

 

 

 

10,162,656

 

 

 

 

 

 

 

 

10,781,250

 

Basic and diluted net income/(loss) per share

 

$

 

0.16

 

 

$

 

(0.05

)

 

$

 

 

 

$

 

(0.00

)

 

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution as well as the Trust Account, which at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts.

Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic  820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet.

Offering Costs

The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A — “Expenses of Offering.” Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to our Public Offering reflected in Deferred offering costs on the accompanying December 31, 2018 balance sheet, and were charged to stockholders’ equity upon the completion of our Public Offering. Accordingly, on the IPO Closing Date, offering costs totaling approximately $22,865,105 (including $22,000,000 in underwriter’s fees), were charged to stockholders’ equity.

Redeemable Common Stock

As discussed in Note 3, all of the 40,000,000 shares of Common Stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation. In accordance with ASC 480, redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Although the Company did not specify a maximum redemption threshold, its amended and restated certificate of incorporation provides that currently, the Company will not redeem its public shares in an amount that would cause its net tangible assets (stockholders’ equity) to be less than $5,000,001.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital.

Accordingly, as of December 31, 2019, 38,713,476 of the 40,000,000 public shares are classified outside of permanent equity at their redemption value.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

The Company accounts for uncertainty in income taxes by recognizing the tax benefit from an uncertain tax position only if it is more than likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits recognized in the financial statements from such a position based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution. The application of income tax law is inherently complex. Laws and regulations in this area are voluminous and are often ambiguous. As such, the Company is required to make many subjective assumptions and judgments regarding income tax exposures. Interpretations of and guidance surrounding income tax law and regulations change over time and may result in changes to the Company's subjective assumptions and judgments, which can materially affect amounts recognized in the balance sheets and statements of operations. The Company recognizes interest and penalties related to uncertain tax positions in other income (expense). No penalties or interest were recorded during the years ended December 31, 2019 or 2018.

The Company may be subject to potential examination by U.S. federal, states or foreign jurisdiction authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income amounts various tax jurisdictions and compliance with U.S. federal, states or foreign tax laws.

The Company is incorporated in the State of Delaware and is required to pay franchise taxes to the State of Delaware on an annual basis.

Cash and Cash Equivalents

The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company continually monitors its positions with and the credit quality of the financial institutions with which it invests. Periodically, the Company may maintain balances in various operating accounts in excess of federally insured limits.

Investments and Cash Held in Trust Account

As of December 31, 2019, the Company had $406,434,959 in the Trust Account which may be utilized for Business Combinations. As of December 31, 2019, the Trust Account consisted of both cash and treasury bills.

The Company’s amended and restated certificate of incorporation provides that, other than the withdrawal of interest to pay taxes, if any, none of the funds held in trust will be released until the earlier of: (i) the completion of the Business Combination; (ii) the redemption of any public shares of common stock properly tendered in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of such public shares of common stock if the Company does not complete the Business Combination within 24 months from the IPO Closing Date; or (iii) the redemption of 100% of the public shares of common stock if the Company is unable to complete a Business Combination within 24 months from the IPO Closing Date, subject to the requirements of law and stock exchange rules.

Recently issued accounting pronouncements not yet adopted

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements based on current operations of the Company.  The impact of any recently issued accounting standards will be re-evaluated on a regular basis or if a Business Combination is completed where the impact could be material.

Going Concern Consideration

If the Company does not complete its Business Combination by February 5, 2021, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the common stock sold as part of the units in the Public Offering, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of franchise and income taxes payable and less up to $100,000 of such net interest which may be distributed to the Company to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s Board of Directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the initial public offering price per unit (the “Units”) in the Public Offering. In addition if the Company fails to complete its Business Combination by February 5, 2021, there will be no redemption rights or liquidating distributions with respect to the warrants, which will expire worthless.

In addition, as of December 31, 2019 and 2018, the Company had current liabilities of $1,355,865 and $486,849, respectively, and working capital of $145,774 and $3,015, respectively, largely due to amounts owed to professionals, consultants, advisors and others who are working on seeking a Business Combination as described in Note 1. Such work is continuing after December 31, 2019 and amounts are continuing to accrue.

v3.20.1
Investments and Cash Held In Trust - Additional information (Details)
Dec. 31, 2019
USD ($)
Investments And Cash Held In Trust [Line Items]  
Investments and cash held in Trust Account $ 406,434,959
United States Treasury Bills  
Investments And Cash Held In Trust [Line Items]  
Investments and cash held in Trust Account 406,434,735
Cash  
Investments And Cash Held In Trust [Line Items]  
Investments and cash held in Trust Account $ 224
v3.20.1
STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Class A Common Stock
Class F Common Stock
Additional Paid-in Capital
Accumulated Deficit/Retained Earnings
Beginning balance at Aug. 28, 2018 $ 0 $ 0 $ 0 $ 0 $ 0
Beginning Balance (in shares) at Aug. 28, 2018   0 0    
Sale of common stock to Sponsor in October 2018 25,000   $ 1,078 23,922  
Sale of common stock to Sponsor in October 2018, shares     10,781,250    
Net (loss) income (21,985)       (21,985)
Ending balance at Dec. 31, 2018 3,015   $ 1,078 23,922 (21,985)
Ending Balance (in shares) at Dec. 31, 2018     10,781,250    
Forfeited Class F Common stock by Sponsor     $ (78) 78  
Forfeited Class F Common stock by Sponsor (in shares)     (781,250)    
Proceeds from initial public offering of Units on February 5, 2019 at $10.00 per Unit 400,000,000 $ 4,000   399,996,000  
Proceeds from initial public offering of Units on February 5, 2019 at $10.00 per Unit (in shares)   40,000,000      
Sale of 6,666,666 Private Placement Warrants to Sponsor on February 5, 2019 at $1.50 per Private Placement Warrant 10,000,000     10,000,000  
Underwriters discounts (8,000,000)     (8,000,000)  
Offering costs charged to additional paid-in capital (865,105)     (865,105)  
Deferred underwriting compensation (14,000,000)     (14,000,000)  
Class A common stock subject to possible redemption; 38,713,476 shares at a redemption price of $10.00 (387,134,760) $ (3,871)   (387,130,889)  
Class A common stock subject to possible redemption; 38,713,476 shares at a redemption price of $10.00,(in shares)   (38,713,476)      
Net (loss) income 5,445,176 $ 5,938,019 $ (492,843)   5,445,176
Ending balance at Dec. 31, 2019 $ 5,448,326 $ 129 $ 1,000 $ 24,006 $ 5,423,191
Ending Balance (in shares) at Dec. 31, 2019   1,286,524 10,000,000    
v3.20.1
Document and Entity Information - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Mar. 13, 2020
Jun. 28, 2019
Entity Information [Line Items]      
Document Type 10-K/A    
Amendment Flag true    
Amendment Description Gores Metropoulos, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K (this “Amendment”) to amend our annual report on Form 10-K for the year ended December 31, 2019, as filed with the Securities and Exchange Commission on March 13, 2020, and is being filed solely to correct the Company’s accelerated filer status included in the submission header and XBRL DEI. The correct filer status for “Accelerated” was marked on the Form 10-K cover page, however the incorrect filer status of “Non-Accelerated” was inadvertently included in the submission header and XBRL DEI file. This Amendment speaks as of the original filing date and does not reflect any events that may have occurred subsequent to the original filing date. In addition, pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended, as a result of this Amendment, the certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed, as exhibits to the original filing have been re-executed and re-filed as of the date of this Amendment and are included as exhibits hereto. Except as stated herein, this Amendment does not reflect events occurring after the filing of the Form 10-K on March 13, 2020 and no attempt has been made in this Amendment to modify or update other disclosures as presented in the Form 10-K. This Form 10-K/A has not been updated for events occurring after the filing of the Form 10-K and no attempt has been made in this Form 10-K/A to modify or update other disclosures as presented in the original filing of the Form 10-K. The following sections have been amended as a result of the restatement: Part IV, Item 15. Exhibits, Financial Statement Schedules In accordance with applicable SEC rules, this Form 10-K/A includes certifications from our Chief Executive Officer and Principal Financial Officer dated as of the date of this filing.    
Document Period End Date Dec. 31, 2019    
Document Fiscal Year Focus 2019    
Document Fiscal Period Focus FY    
Entity Registrant Name Gores Metropoulos, Inc.    
Entity Central Index Key 0001758057    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
Entity Shell Company true    
Entity File Number 001-38791    
Entity Tax Identification Number 83-1804317    
Entity Address, Address Line One 9800 Wilshire Blvd.    
Entity Address, City or Town Beverly Hills    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 90212    
City Area Code 310    
Local Phone Number 209-3010    
Entity Public Float     $ 402.8
Document Annual Report true    
Document Transition Report false    
Entity Incorporation, State or Country Code DE    
Entity Interactive Data Current Yes    
Class A Common Stock      
Entity Information [Line Items]      
Trading Symbol GMHI    
Entity Common Stock, Shares Outstanding   40,000,000  
Title of 12(b) Security Class A Common Stock    
Security Exchange Name NASDAQ    
Class F Common Stock      
Entity Information [Line Items]      
Entity Common Stock, Shares Outstanding   10,000,000  
Warrants      
Entity Information [Line Items]      
Trading Symbol GMHIW    
Title of 12(b) Security Warrants    
Security Exchange Name NASDAQ    
Units      
Entity Information [Line Items]      
Trading Symbol GMHIU    
Title of 12(b) Security Units    
Security Exchange Name NASDAQ    
v3.20.1
Deferred Underwriting Compensation - Additional Information (Details)
12 Months Ended
Dec. 31, 2019
USD ($)
Deferred Underwriting Compensation [Abstract]  
Deferred underwriting compensation $ 14,000,000
Percentage of deferred underwriting discount 3.50%
Deferred underwriting discount if business combination not completed $ 0
v3.20.1
Significant Accounting Policies - Additional Information (Details) - USD ($)
12 Months Ended
Feb. 05, 2019
Dec. 31, 2019
Dec. 31, 2018
Significant Accounting Policies [Line Items]      
Dilutive securities, effect on basic earnings per share   $ 0  
Federal depository insurance coverage amount   $ 250,000  
Class A common stock subject to possible redemption (in shares)   38,713,476 0
Penalties and interest related to uncertain tax positions   $ 0 $ 0
Investments and cash held in Trust Account   $ 406,434,959  
Redemption percentage if business combination is not completed   100.00%  
Dissolution expenses, maximum allowed   $ 100,000  
Redemption rights or liquidating distributions with respect to warrants   0  
Current liabilities   1,355,865 486,849
Working capital   145,774 $ 3,015
Maximum      
Significant Accounting Policies [Line Items]      
Threshold net tangible assets   $ 5,000,001  
Threshold Period to Complete Business Combination from Closing of Public Offering   24 months  
Number of days to redeem the shares if Business combination is not completed   10 days  
Class A Common Stock      
Significant Accounting Policies [Line Items]      
Sale of common stock (in shares)   40,000,000  
IPO      
Significant Accounting Policies [Line Items]      
Offering costs including underwriter's fees   $ 22,865,105  
Underwriter's fees   $ 22,000,000  
IPO | Class A Common Stock      
Significant Accounting Policies [Line Items]      
Sale of common stock (in shares) 40,000,000 40,000,000  
v3.20.1
Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Details) - USD ($)
Dec. 31, 2019
Dec. 31, 2018
Deferred tax assets/(liabilities)    
Tax attribute carryovers $ 32,591 $ 5,635
Valuation allowance (30,238) (5,635)
Net deferred tax assets/(liabilities) $ 2,353 $ 5,635
v3.20.1
STATEMENTS OF CASH FLOWS - USD ($)
4 Months Ended 12 Months Ended
Dec. 31, 2018
Dec. 31, 2019
Cash flows from operating activities:    
Net income/(loss) $ (21,985) $ 5,445,176
Changes in state franchise tax accrual 1,431 198,569
Changes in prepaid assets   (136,399)
Changes in deferred offering costs (437,375) 437,375
Changes in current income tax   1,102,662
Changes in deferred income tax   (2,353)
Changes in accrued expenses, formation and offering costs 335,418 (282,215)
Net cash provided by/(used in) operating activities (122,511) 6,762,815
Cash flows from investing activities:    
Cash deposited in Trust Account   (400,000,000)
Interest reinvested in Trust Account   (6,434,959)
Net cash used in investing activities   (406,434,959)
Cash flows from financing activities:    
Proceeds from notes and advances payable - related party 150,000  
Proceeds from sale of Class F common stock to Sponsor 25,000  
Proceeds from sale of Units in initial public offering   400,000,000
Proceeds from sale of Private Placement Warrants to Sponsor   10,000,000
Repayment of notes and advances payable – related party   (150,000)
Payment of underwriter's discounts and commissions   (8,000,000)
Payment of accrued offering costs   (865,105)
Net cash provided by financing activities 175,000 400,984,895
Increase in cash 52,489 1,312,751
Cash at beginning of period   52,489
Cash at end of period $ 52,489 1,365,240
Supplemental disclosure of non-cash financing activities:    
Deferred underwriting compensation   14,000,000
Cash paid for income and state franchise taxes   $ 342,729
v3.20.1
BALANCE SHEET (Parenthetical) - $ / shares
Dec. 31, 2019
Dec. 31, 2018
Class A subject to possible redemption, shares 38,713,476 0
Class A subject to possible redemption, redemption value per share $ 10  
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, shares authorized 220,000,000  
Class A Common Stock    
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 200,000,000 200,000,000
Common stock, shares issued 1,286,524 0
Common stock, shares outstanding 1,286,524 0
Class F Common Stock    
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 20,000,000 20,000,000
Common stock, shares issued 10,000,000 10,000,000
Common stock, shares outstanding 10,000,000 10,000,000
v3.20.1
Stockholders' Equity - Additional Information (Details)
Dec. 31, 2019
Vote
$ / shares
shares
Dec. 31, 2018
$ / shares
shares
Class Of Stock [Line Items]    
Common stock, shares authorized 220,000,000  
Number of votes for each share | Vote 1  
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, par value | $ / shares $ 0.0001 $ 0.0001
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Class A Common Stock    
Class Of Stock [Line Items]    
Common stock, shares authorized 200,000,000 200,000,000
Common stock, par value | $ / shares $ 0.0001 $ 0.0001
Common stock, shares issued 40,000,000  
Common stock, shares outstanding 40,000,000  
Common stock, shares issued 1,286,524 0
Common stock, shares outstanding 1,286,524 0
Class F Common Stock    
Class Of Stock [Line Items]    
Common stock, shares authorized 20,000,000 20,000,000
Common stock, par value | $ / shares $ 0.0001 $ 0.0001
Common stock, shares issued 10,000,000 10,000,000
Common stock, shares outstanding 10,000,000 10,000,000
v3.20.1
Subsequent Events
12 Months Ended
Dec. 31, 2019
Subsequent Events [Abstract]  
Subsequent Events

10.

Subsequent Events

Management has performed an evaluation of subsequent events through the date of issuance of the financial statements, noting no items which require adjustment or disclosure other than those set forth in the preceding notes to the financial statements.

v3.20.1
Income Taxes
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Income Taxes

6.

Income Taxes

Effective Tax Rate Reconciliation

A reconciliation of the statutory federal income tax expense to the income tax expense from continuing operations provided at December 31, 2019 and 2018 as follows:          

 

 

Year Ended

 

 

Year Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2019

 

 

2018

 

Income tax expense at the federal statutory rate

 

$

 

1,446,224

 

 

$

 

(4,617

)

State income taxes - net of federal income tax benefits

 

 

 

(29,220

)

 

 

 

(1,018

)

Change in valuation allowance

 

 

 

24,603

 

 

 

 

5,635

 

Total income tax expense (benefit)

 

$

 

1,441,607

 

 

$

 

-

 

 

Current/Deferred Taxes

The provision for income taxes consisted of the following for the years ended December 31, 2019 and 2018:

 

 

Year Ended

 

 

Year Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2019

 

 

2018

 

Current income tax expense

 

 

 

 

 

 

 

 

 

 

Federal

 

$

 

1,443,960

 

 

$

 

 

State

 

 

 

 

 

 

 

 

Total current income tax expense

 

$

 

1,443,960

 

 

$

 

 

Deferred income tax expense

 

 

 

 

 

 

 

 

 

 

Federal

 

$

 

(2,353

)

 

$

 

 

State

 

 

 

 

 

 

 

 

Total deferred income tax expense

 

$

 

(2,353

)

 

$

 

 

Provision for income taxes

 

$

 

1,441,607

 

 

$

 

 

 

Deferred Tax Assets and Liabilities

Significant components of the Company’s deferred tax assets and liabilities as of December 31, 2019 and 2018 are as follows:

 

 

Year Ended

 

 

Year Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2019

 

 

2018

 

Deferred tax assets/(liabilities)

 

 

 

 

 

 

 

 

 

 

  Tax attribute carryovers

 

$

 

32,591

 

 

$

 

5,635

 

  Valuation allowance

 

 

 

(30,238

)

 

 

 

(5,635

)

Net deferred tax assets/(liabilities)

 

$

 

2,353

 

 

$

 

5,635

 

 

On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (the “Act”) was signed into law making significant changes to the Internal Revenue Code. The Act contains reform to the corporate tax law including reducing the corporate tax rate to 21%, eliminating the 2-year carryback for net operating losses, and creating an indefinite carryforward period for the net operating losses limited to 80% of taxable income. Due to the Act, the deferred tax balances were calculated using a federal effective tax rate of 21%.

v3.20.1
Public Offering - Additional Information (Details) - USD ($)
12 Months Ended
Feb. 05, 2019
Dec. 31, 2019
Dec. 31, 2018
Class Of Stock [Line Items]      
Proceeds from sale of Units in initial public offering $ 400,000,000 $ 400,000,000  
Percentage of deferred underwriting discount   3.50%  
IPO      
Class Of Stock [Line Items]      
Units sold 40,000,000    
Unit price (in dollars per Unit) $ 10.00    
Proceeds from sale of Units in initial public offering $ 400,000,000    
Upfront underwriting discount (as a percent) 2.00%    
Upfront underwriting discount $ (8,000,000)    
Percentage of deferred underwriting discount   3.50%  
Deferred underwriting discount $ (14,000,000)    
Over-Allotment Option      
Class Of Stock [Line Items]      
Units sold 2,500,000    
Warrant      
Class Of Stock [Line Items]      
Number of shares that contribute each unit   1.33  
Warrant exercisable term if business combination is completed   30 days  
Warrant exercisable term from closing of public offer   12 months  
Warrant expiration term   5 years  
Number of months to complete business combination   24 months  
Class A Common Stock      
Class Of Stock [Line Items]      
Sale of common stock (in shares)   40,000,000  
Unit price (in dollars per Unit)   $ 10.00  
Number of shares that contribute each unit   1  
Common stock, par value   $ 0.0001 $ 0.0001
Class A Common Stock | IPO      
Class Of Stock [Line Items]      
Sale of common stock (in shares) 40,000,000 40,000,000  
Class A Common Stock | Warrant      
Class Of Stock [Line Items]      
Number of shares warrant may be converted   1  
Warrants exercise price (in dollars per share)   $ 11.50  
v3.20.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Schedule of Assets Measured at Fair Value on Recurring Basis

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of December 31, 2019, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Fair values determined by Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves. Fair values determined by Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability:

 

 

 

 

 

 

 

 

 

 

 

 

Significant

 

 

Significant

 

 

 

 

 

 

 

 

 

 

 

 

 

Other

 

 

Other

 

 

 

 

 

 

 

 

Quoted Prices in

 

 

Observable

 

 

Unobservable

 

 

 

December 31,

 

 

Active Markets

 

 

Inputs

 

 

Inputs

 

Description

 

2019

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

Investments and cash held in Trust Account

 

 

 

406,434,959

 

 

 

 

406,434,959

 

 

 

 

 

 

 

 

 

Total

 

$

 

406,434,959

 

 

$

 

406,434,959

 

 

$

 

 

 

$

 

 

v3.20.1
Income Taxes - Provision for Income Taxes (Details)
12 Months Ended
Dec. 31, 2019
USD ($)
Current income tax expense  
Federal $ 1,443,960
Total current income tax expense 1,443,960
Deferred income tax expense  
Federal (2,353)
Total deferred income tax expense (2,353)
Total income tax expense (benefit) $ 1,441,607
v3.20.1
Income Taxes - Schedule of Reconciliation of the Statutory Federal Income Tax Expense (Details) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Income Tax Disclosure [Abstract]    
Income tax expense at the federal statutory rate $ 1,446,224 $ (4,617)
State income taxes - net of federal income tax benefits (29,220) (1,018)
Change in valuation allowance 24,603 $ 5,635
Total income tax expense (benefit) $ 1,441,607  
v3.20.1
Significant Accounting Policies - Reconciliation of Numerator and Denominator Used to Compute Basic and Diluted Net Income/(loss) Per Share (Details) - USD ($)
4 Months Ended 12 Months Ended
Dec. 31, 2018
Dec. 31, 2018
Dec. 31, 2019
Numerator:      
Allocation of net income/(loss) $ (21,985) $ (21,985) $ 5,445,176
Class A Common Stock      
Numerator:      
Allocation of net income/(loss)     $ 5,938,019
Denominator:      
Weighted-average shares outstanding     36,164,000
Basic and diluted net income/(loss) per share     $ 0.16
Class F Common Stock      
Numerator:      
Allocation of net income/(loss) $ (21,985)   $ (492,843)
Denominator:      
Weighted-average shares outstanding 10,781,250   10,162,656
Basic and diluted net income/(loss) per share $ 0.00   $ (0.05)
v3.20.1
Income taxes (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of Reconciliation of the Statutory Federal Income Tax Expense A reconciliation of the statutory federal income tax expense to the income tax expense from continuing operations provided at December 31, 2019 and 2018 as follows:

 

 

Year Ended

 

 

Year Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2019

 

 

2018

 

Income tax expense at the federal statutory rate

 

$

 

1,446,224

 

 

$

 

(4,617

)

State income taxes - net of federal income tax benefits

 

 

 

(29,220

)

 

 

 

(1,018

)

Change in valuation allowance

 

 

 

24,603

 

 

 

 

5,635

 

Total income tax expense (benefit)

 

$

 

1,441,607

 

 

$

 

-

 

 

Provision for Income Taxes

The provision for income taxes consisted of the following for the years ended December 31, 2019 and 2018:

 

 

Year Ended

 

 

Year Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2019

 

 

2018

 

Current income tax expense

 

 

 

 

 

 

 

 

 

 

Federal

 

$

 

1,443,960

 

 

$

 

 

State

 

 

 

 

 

 

 

 

Total current income tax expense

 

$

 

1,443,960

 

 

$

 

 

Deferred income tax expense

 

 

 

 

 

 

 

 

 

 

Federal

 

$

 

(2,353

)

 

$

 

 

State

 

 

 

 

 

 

 

 

Total deferred income tax expense

 

$

 

(2,353

)

 

$

 

 

Provision for income taxes

 

$

 

1,441,607

 

 

$

 

 

 

Significant Components of Deferred Tax Assets and Liabilities

Significant components of the Company’s deferred tax assets and liabilities as of December 31, 2019 and 2018 are as follows:

 

 

Year Ended

 

 

Year Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2019

 

 

2018

 

Deferred tax assets/(liabilities)

 

 

 

 

 

 

 

 

 

 

  Tax attribute carryovers

 

$

 

32,591

 

 

$

 

5,635

 

  Valuation allowance

 

 

 

(30,238

)

 

 

 

(5,635

)

Net deferred tax assets/(liabilities)

 

$

 

2,353

 

 

$

 

5,635

 

 

v3.20.1
Income Taxes - Additional Information (Details)
Dec. 22, 2017
Income Tax Disclosure [Abstract]  
Corporate tax rate 21.00%
Maximum percentage of taxable income in which NOLs limited to deduct 80.00%
v3.20.1
STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Number of warrants sold 6,666,666  
Warrants sold, price per warrant $ 1.50  
Class A common stock subject to possible redemption (in shares) 38,713,476 0
Class A common stock subject to possible redemption, redemption price $ 10  
Class A Common Stock    
Unit price (in dollars per Unit) $ 10.00  
v3.20.1
BALANCE SHEET - USD ($)
Dec. 31, 2019
Dec. 31, 2018
CURRENT ASSETS:    
Cash and cash equivalents $ 1,365,240 $ 52,489
Deferred offering costs   437,375
Prepaid assets 136,399  
Total current assets 1,501,639 489,864
Deferred income tax 2,353  
Investments and cash held in Trust Account 406,434,959  
Total assets 407,938,951 489,864
Current liabilities:    
Accrued expenses, formation and offering costs 53,203 335,418
State franchise tax accrual 200,000 1,431
Notes and advances payable – related party   150,000
Income tax payable 1,102,662  
Total current liabilities 1,355,865 486,849
Deferred underwriting compensation 14,000,000  
Total liabilities 15,355,865 486,849
Commitments and Contingencies:
Class A subject to possible redemption, 38,713,476 and -0- shares at December 31, 2019 and December 31, 2018, respectively (at redemption value of $10 per share) 387,134,760  
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized, none issued or outstanding
Additional paid-in-capital 24,006 23,922
Retained earnings/(accumulated deficit) 5,423,191 (21,985)
Total stockholders’ equity 5,448,326 3,015
Total liabilities and stockholders’ equity 407,938,951 489,864
Class A Common Stock    
Stockholders’ equity:    
Common stock value 129  
Total stockholders’ equity 129  
Class F Common Stock    
Stockholders’ equity:    
Common stock value 1,000 1,078
Total stockholders’ equity $ 1,000 $ 1,078
v3.20.1
Stockholders' Equity
12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Stockholders' Equity

9.

Stockholders’ Equity

Common Stock

The Company is authorized to issue 220,000,000 shares of common stock, consisting of 200,000,000 shares of Class A common stock, par value $0.0001 per share and 20,000,000 shares of Class F common stock, par value $0.0001 per share. Holders of the Company’s Common Stock are entitled to one vote for each share of Common Stock and vote together as a single class. At December 31, 2019, there were 40,000,000 shares of Class A common stock and 10,000,000 shares of Class F common stock issued and outstanding.

Preferred Stock

The Company is authorized to issue 1,000,000 shares of preferred stock, par value $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Board of Directors. At December 31, 2019, there were no shares of preferred stock issued and outstanding.

v3.20.1
Deferred Underwriting Compensation
12 Months Ended
Dec. 31, 2019
Deferred Underwriting Compensation [Abstract]  
Deferred Underwriting Compensation

5.

Deferred Underwriting Compensation

The Company is committed to pay a deferred underwriting discount totaling $14,000,000 or 3.50% of the gross offering proceeds of the Public Offering, to the underwriter upon the Company’s consummation of a Business Combination. The underwriter is not entitled to any interest accrued on the Deferred Discount, and no Deferred Discount is payable to the underwriter if there is no Business Combination.